logo

For the Inventor, By the Inventor

Ravels, Belgium

Gaston S Diels

USPTO Granted Patents = 21


Average Co-Inventor Count = 3.6

ph-index = 8

Forward Citations = 313(Granted Patents)


Location History:

  • Ravels, BE (1987 - 2003)
  • Beerse, BE (2021 - 2024)

Company Filing History:

goldMedal21 out of 2,079 
 
Janssen Pharmaceutica Nv
 patents

Years Active: 1987-2024

Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents
1. 12077521 - Pyrazole derivatives as MALT1 inhibitors (2024-09-03),
2. 10954214 - Pyrazole derivatives as MALT1 inhibitors (2021-03-23),
3. 6656959 - PDE IV inhibiting pyridine derivatives (2003-12-02),
4. 5994376 - 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one compounds and their use (1999-11-30),
5. 5952510 - 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives having PDE (1999-09-14),
6. 5869515 - 1,3-dihydro-2H-imidazol-2-one compounds (1999-02-09),
7. 5629308 - Imidazo [1,2-A] (pyrrolo, thieno or furano) [2,3-D] azepine derivatives (1997-05-13),
8. 5468743 - Imidazo[2,1-b]benzazepine derivatives, compositions and method of use (1995-11-21),
9. 5461050 - Imidazo[1,2-a](pyrrolo, thieno or furano) [3,2a-d]azepine derivatives, (1995-10-24),
10. 5272150 - Hydroxyalkylfuranyl derivatives (1993-12-21),
11. 5258380 - (4-piperidinylmethyl and -hetero)purines (1993-11-02),
12. 5151424 - Pharmacologically active (Bicyclic heterocyclyl)methyl and -hetero) (1992-09-29),
13. 5086056 - 2-(heterocyclylalkyl)imidazopyridines (1992-02-04),
14. 5071846 - Anti-hystaminic [(bicyclic heterocyclyl) methyl and --hetero] (1991-12-10),
15. 5041448 - (4-piperidinylmethyl and -hetero) purines (1991-08-20),

Title: Exploring the Innovations of Gaston S. Diels in Pharmaceutical Patents

Introduction

Gaston S. Diels, based in Ravels, Belgium, is a notable inventor in the pharmaceutical field, with an impressive portfolio of 21 patents. His work primarily focuses on compounds that have significant implications in treating various diseases and disorders, particularly through the modulation of MALT1.

Latest Patents

One of Diels' most recent patents, titled "Pyrazole Derivatives as MALT1 Inhibitors," describes a range of compounds, compositions, and methods specifically aimed at addressing diseases, syndromes, conditions, and disorders influenced by MALT1 modulation. These compounds are represented by a unique formula, showcasing the innovative thinking and research efforts put forth by Diels and his team.

Career Highlights

Gaston S. Diels is associated with Janssen Pharmaceutica NV, a world-renowned company recognized for its contributions to the pharmaceutical industry. His role at the company allows him to leverage cutting-edge research and development processes to drive potential therapeutic advancements.

Collaborations

Throughout his career, Diels has worked alongside esteemed colleagues, including Frans E. Janssens and Joseph L. Torremans. This collaborative environment fosters a rich exchange of ideas and accelerates the development of groundbreaking inventions in the pharmaceutical domain.

Conclusion

Gaston S. Diels exemplifies innovation in the pharmaceutical sector, particularly through his work with pyrazole derivatives and MALT1 inhibitors. His contributions not only enhance the understanding of key biological processes but also pave the way for new therapeutic strategies in the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…